|
Logo placeholder
|
| Location |
Zurich, Switzerland |
| Type |
University |
| Website |
https://www.uzh.ch/ |
| Focus Areas |
Prion , [Alzheimer's Disease](//alzheimers), [Neuroinflammation](//neuroinflammation) |
| Departments |
Institute of Neuropathology |
University of Zurich is Switzerland's largest university, located in Zurich, Switzerland. The institution is home to world-leading research in neurodegenerative , particularly known for pioneering work on prion and neuroinflammation. The Institute of Neuropathology at UZH has been central to understanding the molecular of protein misfolding .
The institution hosts 1 researcher tracked in the NeuroWiki database and maintains 1 department dedicated to neuroscience research. The research programs span Prion , Alzheimer's Disease, and Neuroinflammation, contributing to both basic science understanding and translational approaches for neurodegenerative conditions.
¶ History and Milestones
UZH has a distinguished history in neuroscience research, particularly in neurodegeneration.
Key Historical Milestones:
- 1893: University of Zurich founded
- 1970s: Institute of Neuropathology established
- 1990s: Pioneering prion disease research
- 2000s: Leadership in neuroinflammation research
- 2010: Zurich Neuroscience Center established
- 2020: Advanced imaging and AI approaches
¶ Departments and Centers
- Institute of Neuropathology: Leading neuropathology research
- Zurich Neuroscience Center: Interdisciplinary neuroscience
- Center for Molecular Medicine: Molecular of disease
- Prion protein structure and function
- Mechanism of prion propagation
- Species barriers and strain diversity
- Microglia biology in neurodegeneration
- Inflammatory pathways in AD and PD
- Therapeutic targeting of inflammation
¶ Notable Discoveries and Contributions
- Prion Protein Structure: Understanding PrPsc formation
- Strain Classification: Novel prion strain definitions
- Diagnostic Methods: Ultrasensitive prion detection
- Microglia Activation: Novel pathways in neurodegeneration
- TREM2 Biology: Microglial receptors in AD
- Therapeutic Targets: Anti-inflammatory approaches
- CSF for prion disease
- Inflammatory markers in neurodegeneration
- Novel detection methods
| Researcher |
Focus Areas |
| Adriano Aguzzi |
Prion , Neuroinflammation |
| Marie-Thérèse H. Heeusel |
Neuropathology |
¶ Funding and Resources
- Swiss National Science Foundation (SNSF)
- EU Framework Programs
- Foundation grants
- Neuropathology Laboratory: Histopathology and molecular pathology
- Prion Research Center: Specialized prion research
- Imaging Facility: Advanced microscopy
#- [Alpha-Synuclein](/proteins/alph- [Neuroinflammation](/mechanisms/neu- [Protein Aggregation](/mechanisms/protein-aggregat- [Alpha-Synuclein](/proteins/alph- Neuroinflammationins/tau)
- Aguzzi & Lakkaraju, Nature Reviews Neurology (2022) - Prion disease
UZH maintains European partnerships:
- JPND: EU neurodegeneration research
- Swiss National Science Foundation
- DZNE Partnership: German-Swiss collaboration
- Novel prion therapies: Treatment development
- Microglia biology: Neuroinflammation
- Protein aggregation: Mechanism understanding
- Basic mechanism discovery
- Clinical translation
- Training
¶ Impact and Recognition
- Fundamental prion discoveries
- Neuroinflammation expertise
- European leadership
- Molecular Biology: Protein research
- Cell Culture: Cellular models
- Animal Facility: Transgenic models
- Microscopy: Advanced imaging
- Histology: Tissue analysis
- Flow Cytometry: Cell sorting
- Patient Cohorts: Longitudinal studies
- Clinical Trials: Early-phase studies
- Brain Bank: Tissue collection
- PhD in Neuroscience: Doctoral program
- Master's Programs: Research training
- Neurology Residency: Clinical training
- Neuropathology Fellowship: Sub-specialty
- Research Fellowships: Postdoctoral
- JPND: Neurodegeneration research
- NEURO: European neuroscience
- COST Actions: Collaborative networks
UZH is world-renowned for prion research:
- Prion Protein Structure: Understanding PrP misfolding
- Strain Diversity: Characterization of different strains
- Species Barriers: Transmission between species
- Therapeutic Approaches: Developing treatments
- Creutzfeldt-Jakob Disease: Sporadic, familial, and iatrogenic CJD
- Variant CJD: UK BSE-related disease
- Animal Prion Diseases: Scrapie, BSE, chronic wasting disease
- Cellular Models: In vitro disease modeling
Understanding the role of immune cells in neurodegeneration:
- TREM2 Biology: Microglial receptor in AD
- Inflammatory Pathways: NF-κB, inflammasome
- Phagocytosis: Clearance of pathological
- Neuroprotection: Beneficial inflammation
- Astrocyte Biology: Support cell functions
- Oligodendrocyte: Myelin in neurodegeneration
- Blood-Brain Barrier: Vascular contributions
Specialized clinical services:
- Diagnostic Workup: Including brain biopsy
- Supportive Care: Symptom management
- Clinical Trials: When available
- Family Counseling: Genetic counseling
¶ Training and Collaboration
- Research Coordination: European collaboration
- Funding Programs: Joint grant initiatives
- Data Sharing: Collaborative databases
Close collaboration with German Center for Neurodegenerative Diseases:
- Joint Projects: Cross-border research
- Clinical Trials: Multi-site studies
- Training: Exchange programs
Comprehensive AD research:
- Amyloid Biology: Understanding Aβ aggregation
- Tau Pathology: Mechanisms of tau spreading
- Neuroinflammation: Microglial contributions
- Therapeutic Development: Drug discovery
- Alpha-Synuclein: Aggregation
- LRRK2 Biology: Common genetic risk factor
- Dopaminergic Neurons: Cell death
- Therapeutic Targets: Novel treatments
- Protein Expression: Recombinant
- Protein Purification: Biochemical characterization
- Biophysical Methods: Aggregation analysis
- Cell Culture: Neuronal and glial cultures
- Primary Neurons: Primary cell models
- Stem Cells: iPSC-derived neurons
- Transgenic Mice: Disease models
- Behavior Testing: Cognitive and motor assays
- In Vivo Imaging: Live animal imaging
- First-in-Human: Testing novel compounds
- Safety Studies: Phase I trials
- Dose-Finding: Phase II studies
- Academic Trials: Researcher-initiated studies
- Biomarker Studies: Validation projects
- Observational Studies: Natural history
Major funding source:
- Project Grants: Research funding
- Career Funding: Fellowships and awards
- Infrastructure: Core facilities
Regional collaboration:
- Joint Seminars: Regular meetings
- Shared Resources: Core facilities
- Student Exchange: Training opportunities